| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |